Skip to main content
BBIO
NASDAQ Life Sciences

Novel Kidney-Protective Effects Found for BridgeBio's Acoramidis in ATTR-CM

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$74
Mkt Cap
$14.596B
52W Low
$41.8
52W High
$84.94
52W Position info
77% above low
Off High info
13% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

BBIO sits 77% above its 52-week low of $41.8.

Summary

BridgeBio Pharma announced new post-hoc analyses published in *Circulation:Heart Failure*, demonstrating that its approved drug, acoramidis, provides early and sustained direct kidney-protective effects in ATTR-CM patients. These findings, derived from Phase 2 and Phase 3 ATTRibute-CM studies, show a profile consistent with drugs acting directly on the kidney, a benefit not previously observed with other ATTR-CM therapies. This novel data strengthens acoramidis's competitive position and could expand its market potential by addressing a critical comorbidity in ATTR-CM.

At the time of this announcement, BBIO was trading at $74.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $14.6B. The 52-week trading range was $41.80 to $84.94. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

BBIO - Latest Insights

BBIO
Oct 29, 2026, 4:52 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $70.69
Real-time Price: $76.03 info
Change: +$5.34 (+8%) info
Market Cap: $14.811B info
BBIO
Oct 29, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $71.44
Real-time Price: $76.03 info
Change: +$4.59 (+6%) info
Market Cap: $14.811B info
BBIO
Oct 29, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $70.67
Real-time Price: $76.03 info
Change: +$5.36 (+8%) info
Market Cap: $14.811B info
BBIO
Oct 13, 2026, 6:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $65.75
Real-time Price: $76.03 info
Change: +$10.28 (+16%) info
Market Cap: $14.811B info
BBIO
Oct 11, 2026, 2:30 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $65.35
Real-time Price: $76.03 info
Change: +$10.68 (+16%) info
Market Cap: $14.811B info